Jennifer Leohr

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study

Tim Heise, Helle Linnebjerg, David E. Coutant et al. · Diabetes Obesity and Metabolism · 2020 · 63 citations · Full text

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial

Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell et al. · Clinical Pharmacokinetics · 2020 · 55 citations · Full text

Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry

Hai H. Bui, Jennifer Leohr, Ming‐Shang Kuo · Analytical Biochemistry · 2012 · 48 citations

Lipid Analysis, Biochemistry, Gas Chromatography +11

Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer

Jeffrey R. Infante, Amita Patnaik, Claire F. Verschraegen et al. · Cancer Chemotherapy and Pharmacology · 2017 · 47 citations

Advanced Cancer, Oncology, Medicine +9

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study

Jennifer Leohr, Mary Anne Dellva, David E. Coutant et al. · Clinical Pharmacokinetics · 2020 · 31 citations · Full text